Premenstrual dysphoric disorder (PMDD) is prevalent, more severe than premenstrual syndrome (PMS), and a challenging disorder. The first line of treatment is pharmacotherapy. Non-pharmacological therapy includes aerobic exercise, consumption of complex carbohydrates and frequent meals, relaxation training, light therapy, sleep deprivation, and cognitive-behavioral therapy could be helpful. In this case report, a lady suffering from PMDD and irritable bowel syndrome (IBS) did not respond to antidepressants, painkillers, and melatonin. She used to sit at home and in her room these days, waiting for the PMDD severity to decrease. Her condition reached remission after taking a small dosage of sulpiride and stopped on the last day of the period. The patient is satisfied with the result since concerns about antidepressants are addressed and avoided. This case provides a new approach to using low-dosage sulpiride temporarily every month in patients with both PMDD and IBS. To our knowledge, there have not yet been any studies on this treatment option for PMDD with IBS
Alageel, A. A. S. (2023). Successful Treatment of Premenstrual Dysphoric Disorder with Irritable Bowel Syndrome using Sulpiride. Suez Canal University Medical Journal, 26(8), 16-19. doi: 10.21608/scumj.2023.322608
MLA
Asem Abdualziz S. Alageel. "Successful Treatment of Premenstrual Dysphoric Disorder with Irritable Bowel Syndrome using Sulpiride", Suez Canal University Medical Journal, 26, 8, 2023, 16-19. doi: 10.21608/scumj.2023.322608
HARVARD
Alageel, A. A. S. (2023). 'Successful Treatment of Premenstrual Dysphoric Disorder with Irritable Bowel Syndrome using Sulpiride', Suez Canal University Medical Journal, 26(8), pp. 16-19. doi: 10.21608/scumj.2023.322608
VANCOUVER
Alageel, A. A. S. Successful Treatment of Premenstrual Dysphoric Disorder with Irritable Bowel Syndrome using Sulpiride. Suez Canal University Medical Journal, 2023; 26(8): 16-19. doi: 10.21608/scumj.2023.322608
)
View on SCiNiTO